Evaluation of the performance of nitrate reductase assay for rapid drug-susceptibility testing of Mycobacterium tuberculosis in North India

Journal of Health, Population and Nutrition

Volumn 29, Issue 1, 2011, Pages 20-25

  Gupta, Anamika ^a   Sen, Malay Ranjan ^a   Mohapatra, Tribhuban Mohan ^a   Anupurba, Shampa ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

Antitubercular agents; Drug resistance; India; Multi drug resistant; Mutiple; Mycobacterium tuberculosis; Nitrate reductase assay; Tuberculosis

Indexed keywords

ETHAMBUTOL; ISONIAZID; NITRATE REDUCTASE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ARTICLE; DRUG EFFECT; ENZYMOLOGY; EVALUATION; HUMAN; INDIA; METABOLISM; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MYCOBACTERIUM TUBERCULOSIS; PREDICTIVE VALUE; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SPUTUM;

ANTITUBERCULAR AGENTS; ETHAMBUTOL; HUMANS; INDIA; ISONIAZID; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; NITRATE REDUCTASE; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RIFAMPIN; SENSITIVITY AND SPECIFICITY; SPUTUM; STREPTOMYCIN;

MYCOBACTERIUM TUBERCULOSIS;

EID: 79953104278     PISSN: 16060997     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. World Health Organization. Global tuberculosis control: surveillance, planning, financing. Geneva: World Health Organization, 2008:19. (http://www.who.int/tb/publications/global_report/2008/pdf/fullreport.pdf, accessed on 28 December 2009).
2. World Health Organization. Global tuberculosis control: epidemiology, strategy, financing. WHO report 2009. Geneva: World Health Organization, 2009:1. (WHO/HTM/TB/2009.411).
3. Corbett EL, Marston B, Churchyard GJ, De Cock KM. Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment. Lancet 2006;367:926-37.
4. Guwatudde D, Zalwango S, Kamya MR, Debanne SM, Diaz MI, Okwera A et al. Burden of tuberculosis in Kampala, Uganda. Bull World Health Organ 2003;81:799-805.
5. World Health Organization. The global plan to stop TB 2006-2015: actions for life: towards a world free of tuberculosis. Geneva: World Health Organization, 2006. (WHO/HTM/STB/2006.35).
6. World Health Organization. Global project on antituberculosis drug resistance surveillance: anti-tuberculosis drug resistance in the world. Fourth global report. Annex 9. Geneva: World Health Organization, 2008. 142 p. (WHO/HTM/TB/2008.394).
7. Franzblau SG, Witzig RS, McLaughlin JC, Torres P, Madico G, Hernandez A et al. Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis by using the microplate Alamar Blue assay. J Clin Microbiol 1998;36:362-6.
8. Roberts GD, Goodman NL, Heifets L, Larsh HW, Lindner TH, McClatchy JK et al. Evaluation of BACTEC radiometric method for recovery of mycobacteria and drug susceptibility testing of Mycobacterium tuberculosis from acid-fast smear-positive specimens. J Clin Microbiol 1983;18:689-96.
9. Palomino JC, Traore H, Fissette K, Portaels F. Evaluation of mycobacteria growth indicator tube (MGIT) for drug susceptibility testing of Mycobacterium tuberculosis. Int J Tuber Lung Dis 1999;3:344-8.
10. Birinci A, Coban AY, Ekinci B, Durupinar B. Comparison of the proportion method with mycobacteria growth indicator tube and E-test for susceptibility testing of Mycobacterium tuberculosis. Mem Inst Oswaldo Cruz 2002;97:351-2.
11. Bwanga F, Hoffner S, Haile M, Joloba ML. Direct susceptibility testing for multi drug resistant tuberculosis: a meta-analysis. BMC Infect Dis 2009;9:67.
12. Rossau R, Traore H, De Beenhouwer H, Mijs W, Jannes G, De Rijk P et al. Evaluation of the INNO-LiPA Rif. TB assay, a reverse hybridization assay for the simultaneous detection of Mycobacterium tuberculosis complex and its resistance to rifampin. Antimicrob Agents Chemother 1997;41:2093-8.
13. Golyshevskaia VI, Korneev AA, Chernousova LN, Selina LG, Kazarova TA, Grishina TD et al. [New microbiological techniques in diagnosis of tuberculosis]. Probl Tuberk 1996;6:22-5 [Russian].
14. Angeby KA, Klintz L, Hoffner SE. Rapid and inexpensive drug susceptibility testing of Mycobacterium tuberculosis with a nitrate reductase assay. J Clin Microbiol 2002;40:553-5.
15. Montoro E, Lemus D, Echemendia M, Martin A, Portaels F, Palomino JC. Comparative evaluation of the nitrate reduction assay, the MTT test, and the resazurin microtitre assay for drug susceptibility testing of clinical isolates of Mycobacterium tuberculosis. J Antimicrob Chemother 2005;55:500-5.
16. Sethi S, Sharma S, Sharma SK, Meharwal SK, Jindal SK, Sharma M. Drug susceptibility of Mycobacterium tuberculosis to primary antitubercular drugs by nitrate reductase assay. Ind J Med Res 2004;120:468-71.
17. Kumar M, Khan IA, Verma V, Kalyan N, Qazi GN. Rapid, inexpensive MIC determination of Mycobacterium tuberculosis isolates by using microplate nitrate reductase assay. Diagn Microbiol Infect Dis 2005; 53:121-4.
18. Kumar M, Khan IA, Verma V, Qazi GN. Microplate nitrate reductase assay versus Alamar Blue assay for MIC determination of Mycobacterium tuberculosis. Int J Tuberc Lung Dis 2005;9:939-41.
19. Poojary A, Nataraj G, Kanade S, Mehta P, Baveja S. Rapid antibiotic susceptibility testing of Mycobacterium tuberculosis: it's utility in resource poor settings. Ind J Med Microbiol 2006;24:268-72.
20. Mishra B, Muralidharan S, Srinivasa H. Direct drug susceptibility testing of Mycobacterium tuberculosis to primary anti-tubercular drugs by nitrate reductase assay. Ind J Pathol Microbiol 2009;52:343-4.
21. Visalakshi P, Meharwal SK, Myneedu VP, Behera D. Evaluation of direct method of drug susceptibility testing of Mycobacterium tuberculosis to rifampicin and isoniazid by nitrate reductase assay in a national reference laboratory. Diagn Microbiol Infect Dis 2010;66:148-52.
22. Centro Panamericano de Zoonosis. Tuberculosis bacteriology. Technical note 11. Buenos Aires: Centro Panamericano de Zoonosis, 1988 [Spanish].
23. Canetti G, Fox W, Khomenko A, Mahler HT, Menon NK, Mitchison DA et al. Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. Bull World Health Organ 1969;41:21-43.
24. Canetti G, Froman S, Grosset J, Hauduroy P, Langerova M, Mahler HT et al. Mycobacteria: laboratory methods for testing drug sensitivity and resistance. Bull World Health Organ 1963;29:565-78.
25. Altman DG. Practical statistics for medical research. In: Altman DG, editors. Inter-rater agreement. London: Chapman and Hall/CRC, 1999:403-9.
26. Martin A, Panaiotov S, Portaels F, Hoffner S, Palomino JC, Angeby K. The nitrate reductase assay for the rapid detection of isoniazid and rifampicin resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis. J Antimicrob Chemother 2008;62:56-65.
27. Coban AY, Birinci A, Ekinci B, Durupinar B. Drug susceptibility testing of Mycobacterium tuberculosis with nitrate reductase assay. Int J Antimicrob Agents 2004;24:304-6.
28. Laszlo A, Rahman M, Espinal M, Raviglione M; WHO/IUATLD Network of Supranational Reference Laboratories. Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Reference Laboratory Network: five rounds of proficiency testing, 1994-1998. Int J Tuberc Lun Dis 2002;6:748-56.
29. Martin A, Montoro E, Lemus D, Simboli N, Morcillo N, Velasco M et al. Multicenter evaluation of the nitrate reductase assay for drug resistance detection of Mycobacterium tuberculosis. J Microbiol Methods 2005;63:145-50.
30. Martin A, Palomino JC, Portael F. Rapid detection of ofloxacin resistance in Mycobacterium tuberculosis by two low-cost colorimetric methods: resazurin and nitrate reductase assays. J Clin Microbiol 2005;43:1612-6.
31. Lemus D, Montoro E, Echemendía M, Martin A, Portaels F, Palomino JC. Nitrate reductase assay for detection of drug resistance in Mycobacterium tuberculosis: simple and inexpensive method for low-resource laboratories. J Med Microbiol 2006;55:861-3.
32. Khan A, Sarkar D. A simple whole cell based high throughput screening protocol using Mycobacterium bovis BCG for inhibitors against dormant and active tubercle bacilli. J Microbiol Methods 2008;73:62-8.
33. Musa RH, Ambroggi M, Souto A, Angeby KA. Drug susceptibility testing of Mycobacterium tuberculosis by a nitrate reductase assay applied directly on microscopy-positive sputum samples. J Clin Microbiol 2005;43:3159-61.
34. Shikama ML, Ferro e Silva R, Villela G, Sato DN, Martins MC, Giampaglia CM et al. Multicentre study of nitrate reductase assay for rapid detection of rifampicin-resistant M. tuberculosis. Int J Tuberc Lung Dis 2009;13:377-80.
35. Shikama Mde L, Silva RR, Martins MC, Giampaglia CM, Oliveira RS, Silva RF et al. Rapid detection of resistant tuberculosis by nitrate reductase assay performed in three settings in Brazil. J Antimicrob Chemother 2009;64:794-6.
36. Syre H, Phyu S, Sandvan P, Bjorvatn B, Grewal HM. Rapid colorimetric method for testing susceptibility of Mycobacterium tuberculosis to isoniazid and rifampin in liquid cultures. J Clin Microbiol 2003;41:5173-7.
37. Kent PT, Kubica GP. Public health mycobacteriology: a guide for the level III laboratory. Atlanta, GA: Centers for Disease Control, 1985:96-103.